Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1098 | 1008 | 1499 | 1562 | 3400 | 5759 |
Fund Return | 9.84% | 0.76% | 49.9% | 16.04% | 27.73% | 19.13% |
Place in category | 54 | 27 | 10 | 9 | 2 | 1 |
% in Category | 71 | 21 | 10 | 12 | 2 | 1 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Small Cap Fund Bonus | 515.66B | 12.81 | 32.36 | 25.25 | ||
Reliance Small Cap Fund Dividend | 515.66B | 12.01 | 33.51 | 25.58 | ||
Reliance Small Cap Fund Growth | 515.66B | 12.81 | 32.36 | 25.25 | ||
Reliance Small Cap Fund Dir Bon | 515.66B | 13.19 | 33.51 | 26.46 | ||
Reliance Small Cap Fund Dir Gr | 515.66B | 12.57 | 34.64 | 26.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Direct Growth | 71.61B | 10.30 | 14.94 | 18.35 | ||
Reliance Pharma Fund - Bonus | 71.61B | 9.88 | 13.91 | 17.32 | ||
Reliance Pharma Dividend Payout | 71.61B | 9.07 | 15.26 | 18.39 | ||
Reliance Pharma Fund - Growth | 71.61B | 9.88 | 13.91 | 17.32 | ||
Reliance Pharma Direct Bonus | 71.61B | 10.30 | 14.94 | 18.35 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.37 | 1,519.80 | +0.23% | |
Lupin | INE326A01037 | 7.74 | 1,626.00 | +2.69% | |
Divi's Labs | INE361B01024 | 7.52 | 4,590.90 | +1.52% | |
Cipla | INE059A01026 | 6.26 | 1,482.00 | +0.07% | |
Apollo Hospitals | INE437A01024 | 5.29 | 6,190.00 | -0.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Strong Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review